Status | Study |
Active, not recruiting |
Study Name: A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas Condition: Basal Cell Carcinoma Date: 2013-03-19 Interventions: Drug: Vismodegib Vismodegib 15 |
Completed |
Study Name: Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas Condition: Basal Cell Nevus Syndrome Gorlin's Syndro Date: 2012-03-14 Interventions: Drug: Vismodegib 150 mg per da |
Completed |
Study Name: Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer Condition: Basal Cell Carcinomas Date: 2011-10-26 Interventions: Device: PulseCure pulse generator and Derm-pulse electrode |
Completed |
Study Name: Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) Condition: Basal Cell Carcinoma Gorlin Syndrome Date: 2011-05-06 Interventions: Drug: LDE225 supplied as 100 m |
Withdrawn |
Study Name: Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) Condition: Basal Cell Carcinoma Date: 2010-07-06 Interventions: Drug: LDE225B Cream, 2x daily |
Completed |
Study Name: A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients Condition: Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients Date: 2009-08-18 Interventions: Drug: Vehicle Placebo cream |
Completed |
Study Name: To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) Condition: Basal Cell Nevus Syndrome Gorlin Syndrome Date: 2009-08-05 Interventions: Drug: GDC-0449 capsule, 150 mg, one pill daily, 18 months |
Completed |
Study Name: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back Condition: Skin Carcinoma Date: 2008-10-31 Interventions: Drug: tazarotene Applied to th |
Completed |
Study Name: Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients Condition: Skin Cancer Xeroderma Pigmentosum Ba Date: 2007-11-07 |
Completed |
Study Name: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face Condition: Neoplastic Syndrome Date: 2007-06-20 Interventions: Drug: tazarotene Tazarotene is a member of the acetylenic class of retinoids. |